STOCK TITAN

[Form 4] Durect Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

R. Scott Asen, a director of DURECT Corp (DRRX), reported an insider purchase on Form 4. The filing shows a purchase of 5,917 shares of DURECT common stock on 08/22/2025 at a price of $1.9194 per share. After the reported transaction the filing lists 2,672,529 shares beneficially owned by the reporting person in a direct capacity. The form also records 970,000 shares held indirectly (30,000 via The Asen Foundation and 940,000 via Asen & Co.) where the reporting person disclaims beneficial ownership except to the extent of pecuniary interest. The filing is signed by R. Scott Asen on 08/26/2025.

R. Scott Asen, amministratore di DURECT Corp (DRRX), ha presentato un acquisto da insider nel Modulo 4. La comunicazione indica l'acquisto di 5.917 azioni ordinarie DURECT il 22/08/2025 al prezzo di $1,9194 per azione. Dopo l'operazione segnalata, il modulo riporta 2.672.529 azioni possedute a titolo diretto dalla persona che effettua la segnalazione. Il modulo registra inoltre 970.000 azioni detenute indirettamente (30.000 tramite The Asen Foundation e 940.000 tramite Asen & Co.), sulle quali il dichiarante rinuncia alla titolarità beneficiaria salvo per l'interesse pecuniario. Il documento è firmato da R. Scott Asen il 26/08/2025.

R. Scott Asen, director de DURECT Corp (DRRX), informó una compra de insider en el Formulario 4. La presentación muestra la compra de 5.917 acciones ordinarias de DURECT el 22/08/2025 a un precio de $1,9194 por acción. Tras la operación informada, el formulario lista 2.672.529 acciones propiedad beneficiaria en carácter directo por la persona informante. El formulario también registra 970.000 acciones mantenidas indirectamente (30.000 a través de The Asen Foundation y 940.000 a través de Asen & Co.), sobre las cuales la persona informante renuncia a la propiedad beneficiaria salvo por el interés pecuniario. La presentación está firmada por R. Scott Asen el 26/08/2025.

DURECT Corp (DRRX) 이사 R. Scott Asen이 Form 4에 내부자 매수 신고를 했습니다. 제출서류에는 2025-08-22에 DURECT 보통주 5,917주를 주당 $1.9194에 매수한 것으로 기재되어 있습니다. 신고된 거래 후 해당 제출서류는 신고인이 직접 보유한 주식 수를 2,672,529주로 표시하고 있습니다. 또한 서류에는 신고인이 간접적으로 보유한 970,000주(30,000주는 The Asen Foundation을 통해, 940,000주는 Asen & Co.를 통해)가 기재되어 있으며, 제출인은 금전적 이익 범위를 제외하고는 수익적 소유권을 부인하고 있습니다. 서류는 2025-08-26에 R. Scott Asen이 서명했습니다.

R. Scott Asen, administrateur de DURECT Corp (DRRX), a déclaré un achat d'initié sur le Formulaire 4. Le dépôt indique l'achat de 5 917 actions ordinaires de DURECT le 22/08/2025 au prix de 1,9194 $ par action. Après la transaction déclarée, le formulaire mentionne 2 672 529 actions détenues à titre direct par la personne déclarante. Le formulaire enregistre également 970 000 actions détenues indirectement (30 000 via The Asen Foundation et 940 000 via Asen & Co.), sur lesquelles la personne déclarante décline la propriété bénéficiaire, sauf dans la mesure d'un intérêt pécuniaire. Le document est signé par R. Scott Asen le 26/08/2025.

R. Scott Asen, Direktor von DURECT Corp (DRRX), meldete einen Insiderkauf in Formular 4. Die Einreichung weist den Erwerb von 5.917 Aktien der Stammaktien von DURECT am 22.08.2025 zu einem Preis von $1,9194 je Aktie aus. Nach der gemeldeten Transaktion listet das Formular 2.672.529 Aktien, die die meldende Person in direkter Eigenschaft wirtschaftlich besitzt. Das Formular verzeichnet außerdem 970.000 Aktien, die indirekt gehalten werden (30.000 über The Asen Foundation und 940.000 über Asen & Co.), wobei die meldende Person eine wirtschaftliche Eigentümerschaft außer soweit sie ein pecuniary interest hat, bestreitet. Das Dokument ist von R. Scott Asen am 26.08.2025 unterzeichnet.

Positive
  • Director purchase disclosed: R. Scott Asen reported buying 5,917 shares at $1.9194, demonstrating an insider acquisition.
  • Clear disclosure of indirect holdings: The filing explains 30,000 shares via The Asen Foundation and 940,000 via Asen & Co.
Negative
  • None.

Insights

TL;DR Insider purchase of 5,917 shares at $1.9194 increases the director's direct stake to 2,672,529 shares; transaction size is modest.

The reported open-market purchase is explicit: 5,917 shares acquired on 08/22/2025 at $1.9194. The filing separates direct and indirect holdings, showing significant indirect positions held via a foundation and an advisory firm where the reporting person has voting or investment authority. For valuation context, the filing provides price and share counts but no information on aggregate cost basis or percentage ownership of outstanding shares. This is a routine Section 16 disclosure with no additional corporate actions reported.

TL;DR Director disclosed a small purchase and clarified indirect holdings through related entities, consistent with Section 16 reporting requirements.

The form clearly documents the reporting person's roles and the nature of indirect ownership: Trustee of The Asen Foundation and President of Asen & Co., with voting/dispositive authority over certain shares. The reporting person explicitly disclaims beneficial ownership of those indirectly held shares except for pecuniary interest. The filing is timely and correctly signed, meeting standard governance transparency expectations; it contains no indications of derivative transactions or plan-based trades.

R. Scott Asen, amministratore di DURECT Corp (DRRX), ha presentato un acquisto da insider nel Modulo 4. La comunicazione indica l'acquisto di 5.917 azioni ordinarie DURECT il 22/08/2025 al prezzo di $1,9194 per azione. Dopo l'operazione segnalata, il modulo riporta 2.672.529 azioni possedute a titolo diretto dalla persona che effettua la segnalazione. Il modulo registra inoltre 970.000 azioni detenute indirettamente (30.000 tramite The Asen Foundation e 940.000 tramite Asen & Co.), sulle quali il dichiarante rinuncia alla titolarità beneficiaria salvo per l'interesse pecuniario. Il documento è firmato da R. Scott Asen il 26/08/2025.

R. Scott Asen, director de DURECT Corp (DRRX), informó una compra de insider en el Formulario 4. La presentación muestra la compra de 5.917 acciones ordinarias de DURECT el 22/08/2025 a un precio de $1,9194 por acción. Tras la operación informada, el formulario lista 2.672.529 acciones propiedad beneficiaria en carácter directo por la persona informante. El formulario también registra 970.000 acciones mantenidas indirectamente (30.000 a través de The Asen Foundation y 940.000 a través de Asen & Co.), sobre las cuales la persona informante renuncia a la propiedad beneficiaria salvo por el interés pecuniario. La presentación está firmada por R. Scott Asen el 26/08/2025.

DURECT Corp (DRRX) 이사 R. Scott Asen이 Form 4에 내부자 매수 신고를 했습니다. 제출서류에는 2025-08-22에 DURECT 보통주 5,917주를 주당 $1.9194에 매수한 것으로 기재되어 있습니다. 신고된 거래 후 해당 제출서류는 신고인이 직접 보유한 주식 수를 2,672,529주로 표시하고 있습니다. 또한 서류에는 신고인이 간접적으로 보유한 970,000주(30,000주는 The Asen Foundation을 통해, 940,000주는 Asen & Co.를 통해)가 기재되어 있으며, 제출인은 금전적 이익 범위를 제외하고는 수익적 소유권을 부인하고 있습니다. 서류는 2025-08-26에 R. Scott Asen이 서명했습니다.

R. Scott Asen, administrateur de DURECT Corp (DRRX), a déclaré un achat d'initié sur le Formulaire 4. Le dépôt indique l'achat de 5 917 actions ordinaires de DURECT le 22/08/2025 au prix de 1,9194 $ par action. Après la transaction déclarée, le formulaire mentionne 2 672 529 actions détenues à titre direct par la personne déclarante. Le formulaire enregistre également 970 000 actions détenues indirectement (30 000 via The Asen Foundation et 940 000 via Asen & Co.), sur lesquelles la personne déclarante décline la propriété bénéficiaire, sauf dans la mesure d'un intérêt pécuniaire. Le document est signé par R. Scott Asen le 26/08/2025.

R. Scott Asen, Direktor von DURECT Corp (DRRX), meldete einen Insiderkauf in Formular 4. Die Einreichung weist den Erwerb von 5.917 Aktien der Stammaktien von DURECT am 22.08.2025 zu einem Preis von $1,9194 je Aktie aus. Nach der gemeldeten Transaktion listet das Formular 2.672.529 Aktien, die die meldende Person in direkter Eigenschaft wirtschaftlich besitzt. Das Formular verzeichnet außerdem 970.000 Aktien, die indirekt gehalten werden (30.000 über The Asen Foundation und 940.000 über Asen & Co.), wobei die meldende Person eine wirtschaftliche Eigentümerschaft außer soweit sie ein pecuniary interest hat, bestreitet. Das Dokument ist von R. Scott Asen am 26.08.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ASEN R SCOTT

(Last) (First) (Middle)
222 1/2 EAST 49TH STREET

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DURECT CORP [ DRRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 970,000 I See Footnote(1)
Common Stock 08/22/2025 P 5,917 A $1.9194 2,672,529 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person is deemed to be the beneficial owner of 30,000 shares of Common Stock of The Asen Foundation (the "Foundation") by virtue of being a Trustee of the Foundation and possessing investment authority for the Foundation. The reporting person is deemed to be the beneficial owner of 940,000 shares of Common Stock as President of Asen & Co which provides certain advisory services to managed accounts of Asen & Co., which advisory services include the power to vote and dispose of the shares of Common Stock. The reporting person disclaims beneficial ownership of the shares held indirectly except to the extent of his pecuniary interest.
/s/ R. Scott Asen 08/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did R. Scott Asen report for DRRX on the Form 4?

The filing reports an open-market purchase of 5,917 shares of DURECT common stock on 08/22/2025 at $1.9194 per share.

How many shares does the reporting person own after the transaction?

The Form 4 lists 2,672,529 shares beneficially owned by the reporting person in a direct capacity following the reported transaction.

What indirect holdings did the filing disclose?

The filing discloses 30,000 shares held by The Asen Foundation and 940,000 shares held via Asen & Co., with the reporter describing those as indirect holdings.

Did the reporting person disclaim beneficial ownership of any shares?

Yes. The reporting person states they disclaim beneficial ownership of shares held indirectly except to the extent of their pecuniary interest.

When was the Form 4 signed?

The Form 4 is signed by /s/ R. Scott Asen on 08/26/2025.
DURECT

NASDAQ:DRRX

DRRX Rankings

DRRX Latest News

DRRX Latest SEC Filings

DRRX Stock Data

59.93M
27.26M
11.82%
23.58%
1.29%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CUPERTINO